Troax Group (TROAX) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Jul, 2026Executive summary
Implemented a more decentralized organization from January to empower local decision-making and improve agility, with restructuring effective January 2025.
Europe, especially construction and general industry, remained weak, while Americas and APAC showed strong and exceptional growth, particularly in automotive and warehousing.
Order intake and sales both declined 4% year-over-year to EUR 69.5 million and EUR 68.3 million, respectively, but sequential improvement was noted compared to Q3 and Q4 last year.
EBITA/EBITDA margin decreased to 14.0% from 15.5% year-over-year, mainly due to higher SG&A costs and lower production volumes in Europe.
Working capital discipline maintained stable net debt and a strong balance sheet, supporting continued growth investments.
Financial highlights
Order intake: EUR 69.5 million, down 4% year-over-year (5% organic decline, 1% FX gain).
Sales: EUR 68.3 million, down 4% year-over-year (5% organic decline, 1% FX gain).
EBITDA: EUR 9.5 million (14% margin), down from EUR 11 million (15.5% margin) in Q1 last year.
Adjusted EPS: EUR 0.10, down from EUR 0.12 year-over-year.
Operating/free cash flow: EUR 3.8 million, following typical seasonal patterns.
Outlook and guidance
Expectation of improved free cash flow in the remaining quarters.
SG&A costs expected to decrease in Q2 due to seasonal factors and cost control initiatives.
Capacity adjustments planned in Europe to align with weaker demand, with potential positive cost effects in 2025.
No material order or revenue delays expected to carry into Q2; Q1 order intake seen as representative.
Low net debt provides opportunities for acquisitions in the current macro environment.
Latest events from Troax Group
- Record order intake and sales, but profitability pressured by costs and higher net debt.TROAX
Q2 202617 Jul 2026 - Sales and profit fell due to weak demand and restructuring, but acquisitions support future recovery.TROAX
Q4 20259 Jul 2026 - Order intake and revenues rose 5–6%, but margins declined amid market headwinds.TROAX
Q2 202430 Jun 2026 - Order intake up 18% to EUR 82m on acquisitions, but organic sales and profit declined.TROAX
Q1 202621 Apr 2026 - Sales up 12% and EBITA margin 19.7%, with strong cash flow and global strategic investments.TROAX
Q3 202418 Jan 2026 - Q4 2024 order intake up 12%, EBITA margin 17.2%, strong cash flow, and stable dividend.TROAX
Q4 202423 Dec 2025 - Doubling sales to €550m by 2030, targeting 20% EBITA margin through regional growth and M&A.TROAX
CMD 202520 Nov 2025 - Order intake and sales declined, but cost savings and a strong balance sheet support future growth.TROAX
Q2 202518 Nov 2025 - Order intake and sales fell 7% YoY, but APAC growth and new targets support future optimism.TROAX
Q3 202530 Oct 2025